Recent in Claims/Labeling (page 7 of 7)
Dec 13, 2005 | L. Rigano and N. Lionetti, Rigano Laboratories
In the EU, a newly required “Period After Opening” designation on product labels has re-focused consumer information to address both a product’s safety and its functional performance over time. This has implications for consumers and for product testers.
Dec 13, 2005 | David C. Steinberg, Steinberg & Associates
The global harmonization of ingredient labeling is forever a dream that formulators will chase as new regulations are accepted and product labels are changed accordingly to meet each country’s specifications. In November 2004, Health Canada issued new cosmetics ingredient labeling requirements. 1 Before they were issued, Canada did not require ingredient declarations on labels. If ingredients were listed, formulators faced the unique challenge posed by French language laws in the province of Quebec—if a U.S.-approved label was used, the label needed translating into French, including all International Nomenclature Cosmetic Ingredient (INCI) designations.
Sep 30, 2005 | Ken Klein, Cosmetech Laboratories
Following is a collection of statements easily found on the Internet. I did a Google search got thousands of hits for documents attacking the cosmetic/personal care industry in general, and various ingredients, products and chemists in particular on grounds of safety or efficacy.
Aug 31, 2005 | Johann W. Wiechers, PhD, Uniqema
It is generally accepted by the public that effective cosmetic products can positively influence the well-being of individual consumers. Whereas we can easily measure the skin moisturizing properties of a cosmetic formulation, measuring its precise effects on well-being is much more complex.
May 6, 2003 | R. Rasmussen
The bottom line for any company is to make a profit, and one of the most obvious and visible ways to do this is to claim that their product provides everything the consumer wants.
May 6, 2003 | Charles Fox
This article is the first in a several-part series focusing on claim support. Part 1, published here, centers around aloe barbadensis gel, AHAs, antimicrobials, biopeptides, Coenzyme Q-10, diethylenetriaminepentaacetic acid, evening primrose oil, flavonoi
May 6, 2003 | Charles Fox, Charles Fox Associates
This article is the fourth in a series focusing on claim support. This installment focuses on research in skin physiology in relation to blood circulation, cell turnover, collagen formation, sebum regulation, enzymes, photodamage and wrinkles and line reduction.
May 6, 2003 | Robert J. Buta, Philip G. Trager and Edward J. Murphy, Consumer Product Testing Co., Inc.
To avoid regulatory penalties, a company developing an OTC product must institute properly administered shelf-life testing programs as an integral part of its product development and marketing efforts.
May 6, 2003 | Charles Fox
This article is the third in series focusing on claim support. Part 3, published here, focuses on cationic polymers, polyquaternium hair conditioning, alkaline hair relaxers, protein kinase C, cationic surfactants, penetration pathways, hair swelling and